J. Corral
Impact in
- Oncology top 1%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 40
- Lung Cancer Research Studies 14
- Colorectal Cancer Treatments and Studies 11
- Cancer Immunotherapy and Biomarkers 9
- HER2/EGFR in Cancer Research 4
-
- Lung Cancer Treatments and Mutations 32
- Lung Cancer Diagnosis and Treatment 15
- Gastric Cancer Management and Outcomes 7
- Co-authors
- Tony Mok (10 shared papers)Yi‐Long Wu (8 shared papers)Kazuhiko Nakagawa (10 shared papers)Luis Paz‐Ares (13 shared papers)Adam Płużański (8 shared papers)Rafael Rosell (9 shared papers)Ki Hyeong Lee (6 shared papers)Maria Rita Migliorino (5 shared papers)
- Journals
- Annals of Oncology (9 papers)Journal of Clinical Oncology (8 papers)Journal of Thoracic Oncology (6 papers)Clinical & Translational Oncology (5 papers)Future Oncology (4 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
J. Corral
58 papers receiving 3.4k citations
J. Corral's Hit Papers
Peers
Comparison fields: 5 of 109
- Oncology 2.3k
- Pulmonary and Respiratory Medicine 2.5k
- Cancer Research 457
- Molecular Biology 856
- Radiology, Nuclear Medicine and Imaging 184
Countries citing papers authored by J. Corral
This map shows the geographic impact of J. Corral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Corral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Corral more than expected).
Fields of papers citing papers by J. Corral
This network shows the impact of papers produced by J. Corral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Corral. The network helps show where J. Corral may publish in the future.
Co-authors
The 25 scholars most cited alongside J. Corral, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2017 | 854 |
| 2 | Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial Hit paper breakdown → | 2012 | 447 |
| 3 | PARAMOUNT: Final Overall Survival Results of the Phase III Study of Maintenance Pemetrexed Versus Placebo Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer Hit paper breakdown → | 2013 | 438 |
| 4 | Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR-Activating Mutations Hit paper breakdown → | 2018 | 331 |
| 5 | 2013 | 112 | |
| 6 | 2017 | 92 | |
| 7 | 2012 | 92 | |
| 8 | 2020 | 84 | |
| 9 | 2014 | 68 | |
| 10 | 2020 | 68 | |
| 11 | 2016 | 67 | |
| 12 | 2011 | 67 | |
| 13 | 2014 | 54 | |
| 14 | 2018 | 50 | |
| 15 | 2018 | 50 | |
| 16 | 2012 | 44 | |
| 17 | 2012 | 43 | |
| 18 | 2015 | 41 | |
| 19 | 2019 | 37 | |
| 20 | 2020 | 35 |
About J. Corral
J. Corral is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 60 papers that have together received 3.5k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (32 papers), Lung Cancer Diagnosis and Treatment (15 papers), Lung Cancer Research Studies (14 papers), Colorectal Cancer Treatments and Studies (11 papers), Cancer Immunotherapy and Biomarkers (9 papers), Gastric Cancer Management and Outcomes (7 papers), Cancer Genomics and Diagnostics (6 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Oncology (2.3k citations), Pulmonary and Respiratory Medicine (2.5k citations), Cancer Research (457 citations), Molecular Biology (856 citations) and Radiology, Nuclear Medicine and Imaging (184 citations). J. Corral has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Tony Mok, Yi‐Long Wu, Kazuhiko Nakagawa, Luis Paz‐Ares, Adam Płużański, Rafael Rosell, Ki Hyeong Lee, Maria Rita Migliorino, Xiangdong Zhou and Ying Cheng. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Journal of Thoracic Oncology, Clinical & Translational Oncology and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.